Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this exciting learning session on managing Ph negative Acute lymphoblastic leukemia in adults.
Acute Lymphoblastic Leukemia (ALL) is a cancer of the blood and bone marrow that progresses rapidly without treatment. It can reoccur after being in remission from previous treatment. It has been noted that refractory ALL did not respond to treatment indicating the previous treatments did not kill enough leukemia cells (blasts) to reach complete remission.
Ph-positive ALL is a special type of ALL in which a genetic mutation is observed in the Philadelphia chromosome. In the case of Ph-negative ALL, genetic disparities are also observed and most importantly in Ph neg ALL there is a disproportionate survival rate among the patients.
Managing Ph neg ALL often becomes difficult, however, the procedures of management of Philadelphia chromosome (Ph)–negative acute lymphoblastic leukemia (ALL) have changed dramatically in recent years leading to a positive vibe for the situation.
Therefore, have overall knowledge regarding the management of Ph negative ALL. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Teenagers Frequently Use Delta-8 THC; New Drug-Coated Balloon Treats Blocked Stents.
2.
Immunotherapy after surgery is good for patients with advanced cancer
3.
AI-based liquid biopsy shows promise for detecting brain cancer
4.
Oncologist Sued for Double-Billing; Pharmacy Deserts; 'She Loved Scotch and Pizza'
5.
New BCMA-Directed Therapies Show Promise in Multiple Myeloma
1.
Surprising Symptoms of Prostate Cancer: What You Need to Know
2.
Oncological Surgery Today: Personalized, Interdisciplinary Approaches to Cancer Care
3.
Bridging the Global Divide: Enhancing Psychosocial Care for Cancer Survivors Across Income Settings
4.
Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts
5.
Unlocking the Potential of Reticulocytes: The Key to Enhanced Blood Production
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part XI
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation